Biomarin Pharmaceutical Inc (BMRN)
66.71
+0.05
(+0.08%)
USD |
NASDAQ |
Nov 14, 11:33
Biomarin Pharmaceutical Total Return Level: 66.66 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 66.66 |
November 12, 2024 | 66.13 |
November 11, 2024 | 66.37 |
November 08, 2024 | 67.07 |
November 07, 2024 | 66.94 |
November 06, 2024 | 66.15 |
November 05, 2024 | 66.04 |
November 04, 2024 | 66.01 |
November 01, 2024 | 66.60 |
October 31, 2024 | 65.89 |
October 30, 2024 | 66.68 |
October 29, 2024 | 69.91 |
October 28, 2024 | 70.13 |
October 25, 2024 | 69.73 |
October 24, 2024 | 70.39 |
October 23, 2024 | 69.98 |
October 22, 2024 | 70.53 |
October 21, 2024 | 70.28 |
October 18, 2024 | 70.11 |
October 17, 2024 | 69.47 |
October 16, 2024 | 70.16 |
October 15, 2024 | 70.46 |
October 14, 2024 | 70.27 |
October 11, 2024 | 70.35 |
October 10, 2024 | 69.85 |
Date | Value |
---|---|
October 09, 2024 | 69.80 |
October 08, 2024 | 68.69 |
October 07, 2024 | 68.96 |
October 04, 2024 | 69.51 |
October 03, 2024 | 68.16 |
October 02, 2024 | 69.66 |
October 01, 2024 | 70.10 |
September 30, 2024 | 70.29 |
September 27, 2024 | 70.58 |
September 26, 2024 | 70.24 |
September 25, 2024 | 69.02 |
September 24, 2024 | 69.48 |
September 23, 2024 | 69.13 |
September 20, 2024 | 70.69 |
September 19, 2024 | 71.41 |
September 18, 2024 | 71.14 |
September 17, 2024 | 70.55 |
September 16, 2024 | 69.86 |
September 13, 2024 | 84.90 |
September 12, 2024 | 84.38 |
September 11, 2024 | 84.78 |
September 10, 2024 | 84.85 |
September 09, 2024 | 84.33 |
September 06, 2024 | 84.08 |
September 05, 2024 | 85.12 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
65.89
Minimum
Oct 31 2024
131.03
Maximum
Jul 20 2020
87.03
Average
85.48
Median
Total Return Level Benchmarks
Merck & Co Inc | 335.09 |
Bristol-Myers Squibb Co | 239.89 |
Alnylam Pharmaceuticals Inc | 264.47 |
Repligen Corp | 150.43 |
Bioventus Inc | 11.16 |